M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 32.6 SEK -4.12% Market Closed
Market Cap: 599.9m SEK
Have any thoughts about
Magle Chemoswed Holding AB?
Write Note

Magle Chemoswed Holding AB
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Magle Chemoswed Holding AB
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
M
Magle Chemoswed Holding AB
STO:MAGLE
Current Portion of Long-Term Debt
kr4.3m
CAGR 3-Years
-30%
CAGR 5-Years
20%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Current Portion of Long-Term Debt
kr1.4B
CAGR 3-Years
34%
CAGR 5-Years
10%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Current Portion of Long-Term Debt
kr102.1m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Current Portion of Long-Term Debt
kr33m
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
52%
G
Genovis AB
STO:GENO
Current Portion of Long-Term Debt
kr2.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Current Portion of Long-Term Debt
kr51.4m
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-8%
No Stocks Found

Magle Chemoswed Holding AB
Glance View

Market Cap
599.9m SEK
Industry
Life Sciences Tools & Services

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

MAGLE Intrinsic Value
83.69 SEK
Undervaluation 61%
Intrinsic Value
Price
M

See Also

What is Magle Chemoswed Holding AB's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
4.3m SEK

Based on the financial report for Dec 31, 2023, Magle Chemoswed Holding AB's Current Portion of Long-Term Debt amounts to 4.3m SEK.

What is Magle Chemoswed Holding AB's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
20%

Over the last year, the Current Portion of Long-Term Debt growth was 10%. The average annual Current Portion of Long-Term Debt growth rates for Magle Chemoswed Holding AB have been -30% over the past three years , 20% over the past five years .

Back to Top